Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$191.51 - $216.16 $27.4 Million - $30.9 Million
-143,000 Reduced 88.27%
19,000 $4.03 Million
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $4.23 Million - $5.01 Million
36,000 Added 28.57%
162,000 $20.8 Million
Q3 2022

Nov 09, 2022

BUY
$135.27 - $180.11 $17 Million - $22.7 Million
126,000 New
126,000 $17.2 Million
Q4 2021

Feb 15, 2022

SELL
$142.57 - $190.86 $5.93 Million - $7.94 Million
-41,600 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$137.51 - $190.8 $3.71 Million - $5.15 Million
-27,000 Reduced 39.36%
41,600 $5.78 Million
Q4 2020

Feb 11, 2021

BUY
$164.63 - $211.93 $11.3 Million - $14.5 Million
68,600 New
68,600 $12 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.